Longevity Weekly Review 2026-10-07
Week In Review The Aging Research and Drug Discovery meeting in Boston set the agenda this week, and the headline from it was commercial rather than academic. Eli Lilly and Novo Nordisk, whose GLP-1 drugs are among the best-selling medicines in history, each presented molecular evidence that their products slow